AMGN
AMGN
NASDAQ · Biotechnology

Amgen Inc

S&P 500 Nasdaq 100 Dow Jones Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks
$362.12
+1.57 (+0.44%)
As of Jun 30, 9:30 PM ET ·
Analyst Consensus
Hold
44
Analysts
Very High
Coverage
Buy 22 50%
Hold 19 43%
Sell 3 7%
Price Target
Analyst Price Target -47.3% upside
Low Target $141.50
Average Target $190.87
High Target $279.75
Current Price $362.12
Current
$362.12
Target
$190.87
$141.50 $190.87 avg $279.75
Scenario Analysis
Bear Case
$141.50
-60.9%
Low target
Base Case
$190.87
-47.3%
Avg target
Bull Case
$279.75
+-22.7%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$391.29
-7.5% from high
52-Week Low
$269.77
+34.2% from low
50-Day SMA
$340.27
+6.4% vs SMA
200-Day SMA
$306.48
+18.2% vs SMA
RSI (14)
67.1
Neutral
Target vs 52W High
$190.87
-51.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%